Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Recruiting · NCT06959706 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 1 | 2026-04-16 | NCT06959706 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tagworks Pharmaceuticals BV | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Honor Health | Scottsdale | United States | 27 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| NEXT Dallas | Irving | United States | 18 |
| NEXT San Antonio | San Antonio | United States | 6 |
| NEXT Virginia | Fairfax | United States | 83 |
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |